National Institute on Drug Abuse; Notice of Closed Meeting, 21301 [2018-09901]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 90 / Wednesday, May 9, 2018 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Rodent
Testing to Identify Pharmacotherapies for
Substance Dependence (8936).
Date: May 24, 2018.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 827–5702, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: May 4, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–09901 Filed 5–8–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
amozie on DSK3GDR082PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
VerDate Sep<11>2014
17:39 May 08, 2018
Jkt 244001
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;RFA Panel:
African Health Professional Education
Partnership Initiative.
Date: May 22, 2018.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,6701
Rockledge Drive,Bethesda, MD
20892,(Virtual Meeting).
Contact Person: Shalanda A Bynum, Ph.D.,
MPH,Scientific Review Officer,Center for
Scientific Review,National Institutes of
Health,6701 Rockledge Drive, Room
3206,Bethesda, MD 20892,301–755–
4355,bynumsa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;RFA 17–245:
Mammalian Models for Translational
Research.
Date: May 22, 2018.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,6701
Rockledge Drive,Bethesda, MD 20892(Virtual
Meeting).
Contact Person: Careen K Tang-Toth,
Ph.D.,Scientific Review Officer,Center for
Scientific Review,National Institutes of
Health,6701 Rockledge Drive, Room 6214,
MSC 7804,Bethesda, MD 20892,(301) 435–
3504,tothct@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;RFA–CA–
17–038: Accelerating Colorectal Cancer
Screening and Follow-up: TheMoonshot
Initiative.
Date: May 30, 2018.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suite by Hilton
Washington DC,Chevy Chase Pavilion,4300
Military Road NW,Washington, DC 20015.
Contact Person: Shalanda A Bynum, Ph.D.,
MPH,Scientific Review Officer,Center for
Scientific Review,National Institutes of
Health,6701 Rockledge Drive, Room
3206,Bethesda, MD 20892,301–755–
4355,bynumsa@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review
Group;Behavioral Genetics and Epidemiology
Study Section.
Date: May 30, 2018.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: InterContinental Chicago Hotel,505
North Michigan Avenue,Chicago, IL 60611.
Contact Person: Suzanne Ryan,
Ph.D.,Scientific Review Officer,Center for
Scientific Review,National Institutes of
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
21301
Health,6701 Rockledge Drive, Room 3139,
MSC 7770,Bethesda, MD 20892,(301) 435–
1712,ryansj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;Behavioral
Genetics and Epidemiology: Collaborative
Applications.
Date: May 30, 2018.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: InterContinental Chicago Hotel,505
North Michigan Avenue,Chicago, IL 60611.
Contact Person: Suzanne Ryan,
Ph.D.,Scientific Review Officer,Center for
Scientific Review,National Institutes of
Health,6701 Rockledge Drive, Room 3139,
MSC 7770,Bethesda, MD 20892,(301) 435–
1712,ryansj@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group;Biomedical Imaging
Technology B Study Section.
Date: May 31–June 1, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville,1750
Rockville Pike,Rockville, MD 20852.
Contact Person: Mehrdad Mohseni,
MD,Scientific Review Officer,Center for
Scientific Review,National Institutes of
Health,6701 Rockledge Drive, Room 5211,
MSC 7854,Bethesda, MD 20892,301–435–
0484,mohsenim@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated ReviewGroup;Medical Imaging
Study Section.
Date: May 31–June 1, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda,One
Bethesda Metro Center,7400 Wisconsin
Avenue,Bethesda, MD 20814.
Contact Person: Xiang-Ning Li, MD,
Ph.D.,Scientific Review Officer,Center for
Scientific Review,National Institutes of
Health,6701 Rockledge Drive, Room 5112,
MSC 7854,Bethesda, MD 20892,301–435–
1744,lixiang@csr.nih.gov.
Name of Committee: Vascular and
Hematology Integrated Review Group;
Molecular and Cellular Hematology Study
Section.
Date: June 4–5, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Houston River Oaks,
2712 Southwest Freeway, Houston, TX
77098.
Contact Person: Luis Espinoza, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6183,
MSC 7804, Bethesda, MD 20892, 301–495–
1213, espinozala@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–18–
681: Fundamental Mechanism of Affective
and Decisional Process in Cancer Control.
Date: June 5, 2018.
Time: 10:30 a.m. to 2:00 p.m.
E:\FR\FM\09MYN1.SGM
09MYN1
]]>Agencies
[Federal Register Volume 83, Number 90 (Wednesday, May 9, 2018)]
[Notices]
[Page 21301]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-09901]
[[Page 21301]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Rodent Testing to Identify Pharmacotherapies for
Substance Dependence (8936).
Date: May 24, 2018.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Lyle Furr, Scientific Review Officer, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 827-5702, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: May 4, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-09901 Filed 5-8-18; 8:45 am]
BILLING CODE 4140-01-P
